Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000950170-25-018897

General Counsel gave up 2,440 shares (to pay taxes)

  • General Counsel acquired 6,076 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Samuel George A. III · General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-11 Exercise or conversion : show line 1 in the form +6,076 28,260 D
2025-02-11 Shares withheld for taxes : show line 2 in the form −2,440 $0.65 $1,586 25,820 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-11 Exercise or conversion : show line 3 in the form Restricted Stock Units −6,076 6,075 D
Loading xslF345X05/ownership.xml…